![]() ![]() Wealthier bloc members like Denmark, France, Germany and the Netherlands can better compensate for the loss of confidence in AstraZeneca, because they acquired extra doses of other vaccines - especially Pfizer - through a secondary market after poorer E.U. ![]() “In Britain or Eastern Europe, a big part of the campaigns are based on AstraZeneca,” said Yves Van Laethem, a top epidemiologist who is Belgium’s Covid task force spokesman. countries have been offered a chunk of each vaccine approved in the bloc so far - AstraZeneca, Johnson & Johnson, Moderna and Pfizer - many opted to forgo parts of their share of more expensive or cumbersome vaccines like Pfizer and Moderna early on, instead favoring the AstraZeneca jab. The Moderna and Pfizer vaccines, based on a different technology, have not been associated with similar side effects.Īlthough all E.U. Doctors’ groups have circulated guidance about how to treat the disorder.Īccording to a YouGov poll published last month, 61 percent of the French, 55 percent of Germans and 52 percent of Spaniards consider the AstraZeneca vaccine “unsafe.”Īlmost everywhere across the European Union, many are eager for alternatives. Regulators have asked vaccine recipients and doctors to look out for certain symptoms, including severe and persistent headaches and tiny blood spots under the skin. The pause in the use of Johnson & Johnson’s vaccine in Europe over similar concerns threatens to hurt a sluggish rollout that was just starting to gain momentum, after months of short supplies and logistical problems. Last week, British regulators and the European Union’s medical agency said they had established a possible link between AstraZeneca’s Covid-19 vaccine and very rare, though sometimes fatal, blood clots. Laetitia Vancon for The New York Timesįirst it was AstraZeneca. The Johnson & Johnson vaccine’s rollout has been paused in the European Union. Preparing vaccine doses in Munich last month. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |